United States · FDA National Drug Code directory
Zyvox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0009-5136_59c9a143-a1fa-4eeb-8fb1-dfe22de98d43
- Product NDC
- 0009-5136
- Form
- GRANULE, FOR SUSPENSION
- Composition / generic term
- linezolid
- Labeler
- Pharmacia & Upjohn Company LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20000418
- Source listing expiry
- 20271231
Source-listed ingredients
- LINEZOLID — 100 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 150 mL in 1 BOTTLE (0009-5136-04) · 0009-5136-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →